Amgen, Inc. - Company Profile and SWOT Analysis
Amgen, Inc. - Company Profile and SWOT Analysis
Summary
Amgen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Amgen, Inc. (Amgen or 'the company') is a developer, manufacturer, and marketer of human therapeutics. The company develops products mainly in the areas of oncology/hematology, cardiovascular, neuroscience, bone health, and inflammation. The company's product portfolio includes Prolia , XGEVA, EVENITY, Repatha, Aranesp, and KYPROLIS. It sells its products through pharmaceutical wholesale distributors and through direct-to-consumer channels, including print, online media, and television. Amgen has business presence across the US, Europe, Latin America, the Middle East, and Asia Pacific. The company is headquartered in Thousand Oaks, California, the US.
Scope
Summary
Amgen, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.
Key Highlights
Amgen, Inc. (Amgen or 'the company') is a developer, manufacturer, and marketer of human therapeutics. The company develops products mainly in the areas of oncology/hematology, cardiovascular, neuroscience, bone health, and inflammation. The company's product portfolio includes Prolia , XGEVA, EVENITY, Repatha, Aranesp, and KYPROLIS. It sells its products through pharmaceutical wholesale distributors and through direct-to-consumer channels, including print, online media, and television. Amgen has business presence across the US, Europe, Latin America, the Middle East, and Asia Pacific. The company is headquartered in Thousand Oaks, California, the US.
Scope
- Detailed information on Amgen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments
- Intelligence on Amgen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Amgen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
- Gain understanding of Amgen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Amgen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Amgen, Inc.'s business structure, strategy and prospects.
Table of Contents
Company Snapshot
Amgen, Inc.: Company Overview
Amgen, Inc.: Overview and Key Facts
Amgen, Inc.: Overview
Amgen, Inc.: Key Facts
Amgen, Inc.: Key Employees
Amgen, Inc.: Key Employee Biographies
Amgen, Inc.: Major Products and Services
Amgen, Inc.: Company History
Amgen, Inc.: Management Statement
Amgen, Inc.: Locations and Subsidiaries
Amgen, Inc.: Key Competitors
Amgen, Inc.: Company Analysis
Amgen, Inc.: Business Description
Amgen, Inc.: SWOT Analysis
Amgen, Inc.: SWOT Overview
Amgen, Inc.: Strengths
Amgen, Inc.: Weaknesses
Amgen, Inc.: Opportunities
Amgen, Inc.: Threats
Amgen, Inc.: Corporate Financial Deals Activity
Amgen, Inc.: Financial Deals Overview
Amgen, Inc.: Targets and Partners
Amgen, Inc.: Top Deals 2021 - 2025YTD*
Amgen, Inc.: Advisors
Amgen, Inc.: Top Legal Advisors
Amgen, Inc.: Top Financial Advisors
Amgen, Inc.: Mergers and Acquisitions
Amgen, Inc.: Corporate Venturing
Amgen, Inc.: Capital Raising
Amgen, Inc.: Partnership
Amgen, Inc.: Divestments
Amgen, Inc.: Recent Developments
Amgen, Inc.: News and Events Summary
Amgen, Inc.: Business Expansion
Amgen, Inc.: Contracts
Amgen, Inc.: Corporate Governance
Amgen, Inc.: Financial Deals
Amgen, Inc.: Financial Performance
Amgen, Inc.: Market Developments
Amgen, Inc.: Regulatory and Legal Events
Amgen, Inc.: Research & Development
Amgen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
Company Snapshot
Amgen, Inc.: Company Overview
Amgen, Inc.: Overview and Key Facts
Amgen, Inc.: Overview
Amgen, Inc.: Key Facts
Amgen, Inc.: Key Employees
Amgen, Inc.: Key Employee Biographies
Amgen, Inc.: Major Products and Services
Amgen, Inc.: Company History
Amgen, Inc.: Management Statement
Amgen, Inc.: Locations and Subsidiaries
Amgen, Inc.: Key Competitors
Amgen, Inc.: Company Analysis
Amgen, Inc.: Business Description
Amgen, Inc.: SWOT Analysis
Amgen, Inc.: SWOT Overview
Amgen, Inc.: Strengths
Amgen, Inc.: Weaknesses
Amgen, Inc.: Opportunities
Amgen, Inc.: Threats
Amgen, Inc.: Corporate Financial Deals Activity
Amgen, Inc.: Financial Deals Overview
Amgen, Inc.: Targets and Partners
Amgen, Inc.: Top Deals 2021 - 2025YTD*
Amgen, Inc.: Advisors
Amgen, Inc.: Top Legal Advisors
Amgen, Inc.: Top Financial Advisors
Amgen, Inc.: Mergers and Acquisitions
Amgen, Inc.: Corporate Venturing
Amgen, Inc.: Capital Raising
Amgen, Inc.: Partnership
Amgen, Inc.: Divestments
Amgen, Inc.: Recent Developments
Amgen, Inc.: News and Events Summary
Amgen, Inc.: Business Expansion
Amgen, Inc.: Contracts
Amgen, Inc.: Corporate Governance
Amgen, Inc.: Financial Deals
Amgen, Inc.: Financial Performance
Amgen, Inc.: Market Developments
Amgen, Inc.: Regulatory and Legal Events
Amgen, Inc.: Research & Development
Amgen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
